Lexaria Bioscience Corp (LEXX)

Jun 09, 2026

Lexaria Bioscience (LEXX) Completes Dosing in Key Animal Study - GuruFocus

Jun 09, 2026

Jun 09, 2026

Lexaria completes dosing study on next-generation GLP-1 drugs By Investing.com - Investing.com Nigeria

Jun 09, 2026

Jun 09, 2026

Lexaria completes dosing study on next-generation GLP-1 drugs - Investing.com

Jun 09, 2026

Jun 09, 2026

Lexaria's Animal Study Examining Next-Generation GLP-1 drugs is Underway - Weatherford Democrat

Jun 09, 2026

Jun 09, 2026

Weight-loss injection retatrutide tested as pill in Lexaria animal trial - Stock Titan

Jun 09, 2026

Jun 05, 2026

Whoosh Wellness Launches Physician-Guided Telehealth Platform Offering Oral-First Wellness Protocols and Prescribed Microdosing Programs - GlobeNewswire Inc.

Jun 05, 2026

Jun 03, 2026

Lexaria Bioscience to Attend BIO International Convention as Part of Expanded Business Development Push - citybuzz -

Jun 03, 2026

Jun 03, 2026

Lexaria Attending the BIO International Convention, as Part of a Broader Business Development Program - Investing News Network

Jun 03, 2026

Jun 03, 2026

Lexaria Attending the BIO International Convention, as part of a Broader Business Development Program - TradingView

Jun 03, 2026

Jun 03, 2026

Lexaria drug platform sees record partner interest ahead of BIO - Stock Titan

Jun 03, 2026

May 29, 2026

Lexaria Bioscience Corp.Common Stock (NQ: LEXX - FinancialContent

May 29, 2026

May 29, 2026

Lexaria Bioscience Finds its Niche in the Lucrative GLP-1 Market - The Globe and Mail

May 29, 2026

May 28, 2026

Lexaria Bioscience files to sell 2.76M shares of common stock for holders - MSN

May 28, 2026

May 26, 2026

Lexaria Gets Attention with GLP-1 Test on Deck - Bez Kabli

May 26, 2026

May 22, 2026

LEXX Should I Buy - Intellectia AI

May 22, 2026

May 19, 2026

Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #7 - Investing News Network

May 19, 2026

May 19, 2026

MarketsMedicine Hat News - FinancialContent

May 19, 2026

May 11, 2026

TradingKey - TradingKey

May 11, 2026

May 09, 2026

lxrp_ex991.htm - SEC.gov

May 09, 2026

May 07, 2026

Lexaria Bioscience Releases Second Episode of Investor Video Series - Investing News Network

May 07, 2026

May 07, 2026

What Lexaria's CEO says is next for GLP-1 research in 2026 - Stock Titan

May 07, 2026

May 05, 2026

Lexaria advances semaglutide study with ethics review submission By Investing.com - Investing.com India

May 05, 2026

May 05, 2026

Lexaria Updates Progress on Human Study #7 - Investing News Network

May 05, 2026

May 05, 2026

Lexaria advances semaglutide study with ethics review submission - Investing.com

May 05, 2026

May 05, 2026

Lexaria targets mid-June start for 5-week oral semaglutide study - Stock Titan

May 05, 2026

May 05, 2026

Lexaria Bioscience stock soars after ending $5M stock sale agreement with JonesTrading - MSN

May 05, 2026

May 01, 2026

Lexaria Bioscience Launches Ongoing Investor Video Series to Expand Shareholder Communications - Investing News Network

May 01, 2026

May 01, 2026

Lexaria’s new video series zeroes in on a $75B GLP-1 market - Stock Titan

May 01, 2026

Apr 29, 2026

Lexaria Extends Material Transfer Agreement with PharmaCO Through 2026 for GLP-1 Drug Delivery Technology Evaluation - MEXC

Apr 29, 2026

Apr 29, 2026

Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended - Investing News Network

Apr 29, 2026

Apr 29, 2026

Lexaria Bioscience (LEXX) Extends Collaboration with PharmaCO Th - GuruFocus

Apr 29, 2026

Apr 29, 2026

Lexaria Bioscience (LEXX) Extends Collaboration with PharmaCO Through 2026 - GuruFocus

Apr 29, 2026

Apr 29, 2026

Lexaria extends pharma partnership to evaluate GLP-1 technology By Investing.com - Investing.com South Africa

Apr 29, 2026

Apr 29, 2026

Lexaria extends pharma partnership to evaluate GLP-1 technology - Investing.com

Apr 29, 2026